CLINICAL_TRIALS
trial_result
· 2021-06-04
Clinical Trial Update: A Study of TAS-205 for Duchenne Muscular Dystrophy [Phase 1]
Summary
Phase 1 study update for TAS-205 in Duchenne Muscular Dystrophy has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Taiho Pharmaceutical Co., Ltd. | Conditions: Duchenne Muscular Dystrophy | Phase 1 | Status: COMPLETED | Results posted: 2021-06-04